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Dear Editor, palmoplantar keratodermas (PPKs, OMIM #144200) refer to a large 
phenotypically and genetically heterogeneous group of keratinisation disorders 
characterised by marked hyperkeratosis on the surface of the palms and soles.1  
Striate palmoplantar keratoderma (SPPK) features linear hyperkeratosis of the volar 
aspects of the fingers, extending onto the palms, as well as focal plantar 
keratoderma. The disease is most commonly caused by heterozygous mutations in 
DSG1 encoding desmoglein 1 (DSG1)2 (SPPK1, OMIM #148700) but can also arise 
from mutations in DSP encoding desmoplakin (DSP)3 (SPPK2, OMIM #612908) or 
KRT1 encoding keratin 1 (K1)4 (SPPK3, OMIM #607654). To date, more than 25 
mutations in DSG1 have been identified in patients with SPPK1. These mutations 
were uniformly found to result in a premature termination codon (PTC).5,6 
In this study, we present, to our knowledge, the first case of SPPK caused by a 
missense (rather than PTC-causing) mutation affecting a residue predicted to be of 
critical importance for DSG1-mediated adhesion.  
 
The patient was a 27-year-old female of Jewish origin. She reported thickening of the 
skin of palms and soles since 1 year of age, resulting in pain while walking. She 
denied any additional systemic or dermatologic manifestations apart from yellow 
discolouration of all toenails. Her father and her sister reportedly displayed similar 
clinical features. On examination, the patient exhibited foci of plantar yellowish 
fissured hyperkeratotic skin involving weight bearing areas as well as subtle linear 
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hyperkeratosis of the volar aspects of the fingers (Fig. 1a). Haematoxylin and eosin 
staining of a skin biopsy showed hypergranulosis, marked orthohyperkeratosis and 
widening of the intercellular spaces between keratinocytes. (Fig. 1b).  
 
To identify the causative mutation underlying SPPK in the patient, after obtaining 
ethical approval and informed consent, we used direct sequencing of gDNA to fully 
sequence all coding exons of DSG1, KRT1, DSP and KRT16. We discovered a 
heterozygous A to G transition at position 254 (c.254A>G) within exon 4 (Fig. 1c) of 
the DSG1 gene (reference sequence Ensembl accession number 
ENST00000257192.4), resulting in a p.Y85C substitution. The sequence variation 
was not detected in 629 Jewish healthy controls and was not found in the following 
genomic databases: NCBI, UCSC, HGMD, ESP, ExAC, 1000 genomes and 
ENSEMBL, comprising a total of more than 58,000 individual sequences. The 
p.Y85C variation is predicted to be deleterious by two prediction tools (Polyphen2 
score 1, range 0–1; SIFT scores 0, range 1–0) and was found to affect a highly 
conserved residue (Conseq score = 9, range 1-9). No mutations were identified in 
KRT1, DSP or KRT16. 
 
To assess the consequences of the mutation, we modeled the wildtype and the 
mutant DSG1 proteins using three prediction tools (Fig. 1d): SWISS PROT7 and 
LOMETS8 predictions were based on the crystal structure previously determined for 
the human DSG2 ectodomain (PDB code 5ERD, chain A, 36% identity) while 
PHYRE29 was used based on the human DSG3 ectodomain (PDB code 5EQX, chain 
A, 55% identity). Similarity between the model structures was assessed using 
PyMOL alignment (The PyMOL Molecular Graphics System, Version 1.8 
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Schrödinger, LLC).     
Like other members of the cadherin superfamily, desmosomal cadherins are thought 
to form trans-adhesive dimers, which rely on the interaction between the conserved 
tryptophan (W2) of one molecule and a specific hydrophobic pocket, serving as an 
acceptor site, on the interacting molecule from the opposing cell.10-13 This was 
recently shown to depend predominantly on a heterotypic interaction between the 
donor site of a desmocollin molecule and the acceptor pocket of a DSG molecule,14 
which is lined by the side chains of specific conserved residues including Y85 
(numbered Y36 in the final DSG chain).12-14 
Accordingly, we found that the affected amino acid, Y85, resides within the first 
extracellular domain (EC1) of the protein (Fig. 1e), inside a hydrophobic-positively 
charged area (Fig. 1f). The p.Y85C mutation could affect the binding capability of the 
hydrophobic pocket in several ways. First, while the hydroxyl side chain of Y85 was 
found to reach the inner part of this pocket, the C85 mutation is lacking the length to 
do so (Fig. 1f). Additionally, the mutant C85 residue is predicted to aberrantly interact 
with C127, a part of the adhesive interface of the pocket,13 and could potentially form 
a disulfide bond either through an intramolecular cis-interaction, due to proximity of 
the two amino acids, or through a trans-interaction with another bound desmosomal 
cadherin. When we used the same modeling tools to examine the effect of p.V83D 
and p.R86C, both highly rare heterozygous non-pathogenic variants in close 
proximity to p.Y85C, we discovered that although residing close to the hydrophobic 
pocket, they are not predicted to disturb its binding capability or to have an effect on 
DSG1 dimerisation (Fig. 1g).  
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To conclude, we describe here the first case of SPPK resulting from a heterozygous 
missense (as opposed to nonsense or frameshift) mutation in the DSG1 gene to our 
knowledge. Protein modeling predicts this mutation to abolish DSG1-mediated 
adhesive function, thus resulting in what could be manifested as functional 
haploinsufficiency. Of interest, DSG1 has been shown to downregulate the 
Ras/MAPK pathway by interacting with Erbin; elevated Ras activity, resulting from 
DSG1 deficiency, is therefore thought to trigger cellular mechanisms leading to 
hyperkeratosis in SPPK.15 Whether missense mutations in the extracellular domain 
affect this regulatory pathway remains to be determined. In addition to the relevance 
of these data to PPK diagnostics, the putative mode of action of the mutation 
identified in the present study emphasises the importance of the role of DSG1-
mediated adhesive function in palmoplantar skin. 
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Legends to figures 
 
Figure 1. Clinical features, mutation analysis and protein modeling. (a) The 
patient presented with foci of plantar hyperkeratosis involving weight bearing areas 
with multiple skin fissures (left panel). Linear hyperkeratosis of the volar aspects of 
the fingers was also observed (right panel); (b) Hematoxylin and eosin staining of a 
skin biopsy obtained from the skin of the patient demonstrates hypergranulosis, 
marked orthohyperkeratosis and widening (arrows) of the intercellular spaces 
between keratinocytes, compatible with keratoderma (scale bar = 100 μm); (c) Direct 
sequencing of gDNA revealed a A>G transition at position c.254 within exon 4 of 
DSG1 (upper panel), compared to wild-type sequence (lower panel). (d) Comparison 
between the molecular model of the human DSG1 protein based on three prediction 
tools: LOMETS (green), SWISS PROT (magenta) and PHYRE2 (cyan) shows that all 
the structures are similar (RMSD<4 with PyMOL alignment) and that the Y85 amino 
acid is located in the first domain (in red, highlighted by black oval). (e) A schematic 
representation of the DSG1 molecule shows that the p.Y85C mutation is located 
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inside the EC1 domain of the protein. EC, extracellular domain; EA, extracellular 
anchoring domain; P, propeptide region; SP, signal peptide; TM, transmembrane 
domain (protein scheme modified from Hershkovitz et al5); (f) Mutation modeling was 
performed based on the above models. The protein molecules are overlaid with 
semi-transparent calculated electrostatic potential (blue-positive, red-negative) 
created using PyMOL. Y85 (in red) is located in a hydrophobic-positively charged 
pocket-shaped surface, predicted to serve as a pathway for DSG1 binding. While the 
hydroxyl of the tyrosine lies within the inner part of the pocket (left panel), the mutant 
C85 substitution is lacking the length to reach its inner rim (right panel). (g) Modeling 
of two rare heterozygous variants in close proximity to Y85 (in red) was performed 
based on the above models. The p.V83D variant (in purple, right panel) resides 
further away from the hydrophobic pocket and will lead to a negatively charged 
glutamic acid that is not predicted to alter the negatively charged area of the wild type 
p.V83 (in purple, left panel). p.R86 (in green, left panel) is located in proximity of the 
hydrophobic pocket and of p.C127 (in black) but faces the opposite direction. The 
p.R86C variant (in green, right panel) is not predicted to affect the binding capability 
of the hydrophobic pocket or to form a disulphide bond with p.C127. 
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